We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

148 hedge funds and large institutions have $661M invested in Sarepta Therapeutics in 2016 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 20

44% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 34

12% more funds holding

Funds holding: 132 → 148 (+16)

3% less capital invested

Capital invested by funds: $680M → $661M (-$19.4M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

38% less call options, than puts

Call options by funds: $270M | Put options by funds: $436M

Holders
148
Holders Change
+16
Holders Change %
+12.12%
% of All Funds
3.95%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
36
Increased
49
Reduced
34
Closed
20
Calls
$270M
Puts
$436M
Net Calls
-$165M
Net Calls Change
-$167M

Top Buyers

1
Jennison Associates
Jennison Associates
New York
+$19.4M
2
State Street
State Street
Massachusetts
+$11.6M
3
Morgan Stanley
Morgan Stanley
New York
+$9.67M
4
Group One Trading
Group One Trading
Illinois
+$9.41M
5
MP
Mangrove Partners
Connecticut
+$9.12M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$25.1M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$21.2M
3
TCP
Tourbillon Capital Partners
New York
-$15.7M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$13.9M
5
PC
PointState Capital
New York
-$13.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$5.61M +$225K +12,146 +4%
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$4.98M +$4.43M +239,179 +1,081%
TCIM
28
TIAA CREF Investment Management
New York
$4.94M +$781K +42,175 +19%
EMFAT
29
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.71M +$4.58M +247,086 New
EA
30
Emerald Advisers
Pennsylvania
$4.49M +$4.36M +235,506 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$4.23M +$42.3K +2,282 +1%
ARTA
32
A.R.T. Advisors
New York
$4.02M -$3.18M -171,430 -45%
Barclays
33
Barclays
United Kingdom
$3.95M +$3.68M +198,661 +2,297%
GTC
34
Ghost Tree Capital
New York
$3.81M +$3.7M +200,000 New
MSU
35
Mizuho Securities USA
New York
$3.33M +$3.23M +174,400 New
BIM
36
BlackRock Investment Management
Delaware
$3.2M +$219K +11,825 +8%
QIM
37
Quantitative Investment Management
Virginia
$3.2M +$3.11M +167,800 New
Citadel Advisors
38
Citadel Advisors
Florida
$3.14M -$25.1M -1,357,309 -89%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$3.09M -$94.5K -5,100 -3%
CG
40
Cutler Group
California
$2.96M +$1.09M +59,021 +61%
Charles Schwab
41
Charles Schwab
California
$2.93M +$51.2K +2,766 +2%
PC
42
PointState Capital
New York
$2.86M -$13.9M -750,000 -83%
BA
43
BlackRock Advisors
Delaware
$2.72M +$2M +108,221 +313%
PPA
44
Parametric Portfolio Associates
Washington
$2.6M +$2.05M +110,619 +431%
RSCM
45
Rock Springs Capital Management
Maryland
$2.5M – – –
ACP
46
Acuta Capital Partners
California
$2.48M +$2.41M +130,000 New
GC
47
Guggenheim Capital
Illinois
$2.36M +$2.29M +123,869 New
TA
48
Teachers Advisors
New York
$2.3M +$89.8K +4,847 +4%
GPCM
49
Granite Point Capital Management
Massachusetts
$2.19M +$2.13M +115,000 New
Norges Bank
50
Norges Bank
Norway
$2.18M +$2.11M +114,178 New
1
2
3 4 5

SRPT Hedge Fund Activity: Q2 2016 in Review

148 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q2 2016, worth a combined $661M — down 2.9% from $680M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new SRPT positions and 20 closed out — a net gain of 16 holders — while 49 added to existing stakes and 34 trimmed.

The largest buyer was Jennison Associates, opening a new position worth an estimated $19.4M. The largest seller was Citadel Advisors, cutting an estimated $25.1M.

  • 148 institutional investors held Sarepta Therapeutics (SRPT) as of Q2 2016, up from 132 in Q1 2016.
  • Funds reported $661M of Sarepta Therapeutics stock for Q2 2016, down 2.9% quarter-over-quarter.
  • 36 funds opened new Sarepta Therapeutics positions in Q2 2016 and 20 closed out, a net change of +16 holders.
  • The largest Sarepta Therapeutics buyer in Q2 2016 was Jennison Associates, an estimated $19.4M added.
  • The largest Sarepta Therapeutics seller in Q2 2016 was Citadel Advisors, an estimated $25.1M sold.

Based on aggregated 13F filings for Q2 2016.